Diurnal Group PLC (LSE:DNL) - Share price - Overview

Stock Report

Diurnal Group PLC DNL

Last Price
GBX119.50

Day Change
2.00|1.70%

As of 20/01/2017
16:47:37 GMT | GBX
Minimum 15 Minutes Delay.

Last Close117.50p
Day Range120.00 - 120.00
Mkt Cap61.35Mil
52-Wk Range105.00 - 153.00
Yield %0.00
ISINGB00BDB6Q760
Volume10,078
P/E-7.97
P/SInfinity
P/CF-10.42

Share Price

Total Returns 20/01/2017

 Chg (%)  
More ...
Diurnal Group PLC12.21 
FTSE 100 TR GBP2.27
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-0.94-2.73-6.99
Net Profit-0.88-2.69-6.57
Reported EPS-1.69-5.15-15.00
Balance Sheet
Current Assets1.076.4530.64
Non Current Assets0.020.020.01
Total Assets1.086.4630.65
Current Liabilities0.140.421.48
Total Liabilities1.410.424.72
Total Equity-0.326.0425.93
Cash Flow
Operating Cash Flow-0.89-2.69-5.55
Net Change in Cash0.394.6910.04
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017-14.35-26.10--4.50---
2018-15.94-27.91--4.21---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
16/01/2017PurchaseAlan Raymond110.009,0009,900.00
13/01/2017PurchaseMr. Peter Allen105.0040,00042,000.00
13/01/2017PurchaseMr. John Goddard108.009,2489,988.00
13/01/2017PurchaseSam Williams108.009,2489,988.00

Company Profile

Diurnal Group PLC is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
 

Sector

Drug Manufacturers - Specialty & Generic

Market Position

1042 of 1849 Companies

Index

Outlook

(14/10/2016) no outlook statement

Next Event 30/03/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-4.3413.7215.81
Div Yld (E)0.004.094.09
PEG (E)0.00-1.520.82
ROCE-23.76197.96-27.23
Op Mrgn0.00-13.98-30.21
EPS Grwth0.0012.0425.45
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Peter Allen
Chief Executive OfficerMartin Whitaker
Chief Financial OfficerMr. Richard Bungay
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.